Cargando…

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

BACKGROUND: This study aimed to determine whether single nucleotide polymorphisms (SNPs) in genes involved in DNA repair or metabolism of taxanes or platinum could predict toxicity or response to first-line chemotherapy in ovarian cancer. METHODS: Twenty-six selected SNPs in 18 genes were genotyped...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambrechts, Sandrina, Lambrechts, Diether, Despierre, Evelyn, Van Nieuwenhuysen, Els, Smeets, Dominiek, Debruyne, Philip R, Renard, Vincent, Vroman, Philippe, Luyten, Daisy, Neven, Patrick, Amant, Frédéric, Leunen, Karin, Vergote, Ignace
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359565/ https://www.ncbi.nlm.nih.gov/pubmed/25881102 http://dx.doi.org/10.1186/s40360-015-0001-5

Ejemplares similares

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

Increased expression of placental growth factor in high-grade endometrial carcinoma
por: COENEGRACHTS, LIEVE, et al.
Publicado: (2013)

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype
por: Brouckaert, Olivier, et al.
Publicado: (2015)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification
por: Olbrecht, Siel, et al.
Publicado: (2021)

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013)

Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
por: De Wispelaere, Wout, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
por: Vandenput, I, et al.
Publicado: (2009)

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
por: Prenen, Hans, et al.
Publicado: (2015)

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
por: Maenhoudt, Nina, et al.
Publicado: (2020)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study
por: Jansen, Jolien, et al.
Publicado: (2023)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks
por: Zhao, Hui, et al.
Publicado: (2014)

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma
por: Amant, F, et al.
Publicado: (2007)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis
por: Rothé, Françoise, et al.
Publicado: (2022)

Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer
por: Michielsen, K, et al.
Publicado: (2015)

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors
por: Pfeil, Alena M, et al.
Publicado: (2014)

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers
por: Bartlett, Thomas E., et al.
Publicado: (2015)

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period
por: Lefrère, Hanne, et al.
Publicado: (2021)

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
por: Qian, Junbin, et al.
Publicado: (2020)

Whole-body diffusion-weighted MRI versus CT for detection, restaging and operability assessment of recurrent ovarian carcinoma
por: Michielsen, K, et al.
Publicado: (2014)

Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial
por: Devoogdt, Nele, et al.
Publicado: (2011)

The footprint of the ageing stroma in older patients with breast cancer
por: Brouwers, Barbara, et al.
Publicado: (2017)

Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis
por: Buysschaert, Ian, et al.
Publicado: (2008)

SYST-27 INTERROGATION OF THE TUMOR IMMUNE MICROENVIRONMENT REVEALS DISTINCT IMMUNOSUPPRESSIVE LANDSCAPES IN GLIOBLASTOMA
por: Weng, Linqian, et al.
Publicado: (2023)

TRP channel expression correlates with the epithelial–mesenchymal transition and high-risk endometrial carcinoma
por: Van den Eynde, Charlotte, et al.
Publicado: (2021)

Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report
por: Amant, Frédéric, et al.
Publicado: (2010)

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
por: De Smedt, Linde, et al.
Publicado: (2017)

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
por: Michielsen, K, et al.
Publicado: (2015)

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer
por: Svoboda, Martin, et al.
Publicado: (2016)

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
por: Gevaert, Olivier, et al.
Publicado: (2008)

FISH analysis of PTEN in endometrial carcinoma. comparison with SNP arrays and MLPA
por: Maiques, Oscar, et al.
Publicado: (2014)

Exposure–response analysis of endoxifen serum concentrations in early-breast cancer
por: Sanchez-Spitman, Anabel Beatriz, et al.
Publicado: (2020)

The genetic landscape of 5T models for multiple myeloma
por: Maes, Ken, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m8j53el1ieef6d4roh5ahv6dun